Answers are grounded in this paper and cite their sources.
The synthesis of plant-derived nanoparticles, in particular, constitutes a unique and promising field and is attracting significant interest due to its expanding applications in the healthcare sector. In our study, chitosan nanoparticles (Cs-NPs) were biologically synthesized and characterized using C. quinoa Willd. extract. The synthesized Cs-NPs were characterized by UV-Vis, ZETA, SEM, XRD, and FT-IR analyses. An analysis of the characterization results revealed that the Cs-NPs exhibit a light absorption peak at 250 nm, a surface charge of 22.2 mV, and an average size of approximately 52 nm. The cytotoxic potential of the C. quinoa extract-derived Cs-NPs was tested on A549 lung cancer cells and the CCD-19Lu normal lung cell line. Increasing concentrations of Cs-NPs were applied to both cell lines for 48 hours. The cytotoxic effects were measured using the 3-(4,5-dimethylthiazol-2,5-diphenyltetrazolium bromide) (MTT) assay. It was found that an increase in Cs-NP concentrations increased cell death in lung cancer cells compared to the control group. The IC50 value for the A549 cells was determined to be 13.266 µg/mL (r²=0.900), while the IC50 value for the CCD-19Lu cells was 140.381 µg/mL (r²=0.927).Our findings demonstrate that C. quinoa extract can be effectively used for the biosynthesis and characterization of Cs-NPs, and can be developed as an alternative agent for future studies in the treatment of lung cancer.
No takes yet. Share an insight, caveat, or question.
Leblebici et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: